Phase I study investigating the pharmacokinetic impact of delayed administration of USL255

Trial Profile

Phase I study investigating the pharmacokinetic impact of delayed administration of USL255

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Jun 2014

At a glance

  • Drugs Topiramate (Primary)
  • Indications Epilepsy
  • Focus Pharmacokinetics
  • Most Recent Events

    • 06 Jun 2014 New trial record
    • 10 Dec 2013 According to a Upsher-Smith media release, the results of this trial have been presented at American Epilepsy Society's (AES) 67th Annual Meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top